458 related articles for article (PubMed ID: 36450978)
21. Clonal haematopoiesis of indeterminate potential-related mutations and outcome in dilated and ischaemic cardiomyopathy.
Wu JMF; Bekfani T; Hinze A; Westphal JG; Steinacker B; Zeller M; Hartmann C; Möbius-Winkler S; Hochhaus A; Schulze PC; Ernst T
ESC Heart Fail; 2022 Dec; 9(6):3954-3960. PubMed ID: 35979940
[TBL] [Abstract][Full Text] [Related]
22. A Vicious Circle of Clonal Haematopoiesis of Indeterminate Potential and Cardiovascular Disease.
Ehlert CA; Hilgendorf I
Hamostaseologie; 2021 Dec; 41(6):443-446. PubMed ID: 34942657
[TBL] [Abstract][Full Text] [Related]
23. Clonal hematopoiesis associated with epigenetic aging and clinical outcomes.
Nachun D; Lu AT; Bick AG; Natarajan P; Weinstock J; Szeto MD; Kathiresan S; Abecasis G; Taylor KD; Guo X; Tracy R; Durda P; Liu Y; Johnson C; Rich SS; Van Den Berg D; Laurie C; Blackwell T; Papanicolaou GJ; Correa A; Raffield LM; Johnson AD; Murabito J; Manson JE; Desai P; Kooperberg C; Assimes TL; Levy D; Rotter JI; Reiner AP; Whitsel EA; Wilson JG; Horvath S; Jaiswal S;
Aging Cell; 2021 Jun; 20(6):e13366. PubMed ID: 34050697
[TBL] [Abstract][Full Text] [Related]
24. Clonal haematopoiesis, ageing and kidney disease.
Vlasschaert C; Lanktree MB; Rauh MJ; Kelly TN; Natarajan P
Nat Rev Nephrol; 2024 Mar; 20(3):161-174. PubMed ID: 37884787
[TBL] [Abstract][Full Text] [Related]
25. Clonal haematopoiesis of indeterminate potential: intersections between inflammation, vascular disease and heart failure.
Mooney L; Goodyear CS; Chandra T; Kirschner K; Copland M; Petrie MC; Lang NN
Clin Sci (Lond); 2021 Apr; 135(7):991-1007. PubMed ID: 33861346
[TBL] [Abstract][Full Text] [Related]
26. Clonal haematopoiesis of indeterminate potential predicts incident cardiac arrhythmias.
Schuermans A; Vlasschaert C; Nauffal V; Cho SMJ; Uddin MM; Nakao T; Niroula A; Klarqvist MDR; Weeks LD; Lin AE; Saadatagah S; Lannery K; Wong M; Hornsby W; Lubitz SA; Ballantyne C; Jaiswal S; Libby P; Ebert BL; Bick AG; Ellinor PT; Natarajan P; Honigberg MC
Eur Heart J; 2024 Mar; 45(10):791-805. PubMed ID: 37952204
[TBL] [Abstract][Full Text] [Related]
27. Full spectrum of clonal haematopoiesis-driver mutations in chronic heart failure and their associations with mortality.
Kiefer KC; Cremer S; Pardali E; Assmus B; Abou-El-Ardat K; Kirschbaum K; Dorsheimer L; Rasper T; Berkowitsch A; Serve H; Dimmeler S; Zeiher AM; Rieger MA
ESC Heart Fail; 2021 Jun; 8(3):1873-1884. PubMed ID: 33779075
[TBL] [Abstract][Full Text] [Related]
28. Genetic modification of inflammation- and clonal hematopoiesis-associated cardiovascular risk.
Yu Z; Fidler TP; Ruan Y; Vlasschaert C; Nakao T; Uddin MM; Mack T; Niroula A; Heimlich JB; Zekavat SM; Gibson CJ; Griffin GK; Wang Y; Peloso GM; Heard-Costa N; Levy D; Vasan RS; Aguet F; Ardlie KG; Taylor KD; Rich SS; Rotter JI; Libby P; Jaiswal S; Ebert BL; Bick AG; Tall AR; Natarajan P
J Clin Invest; 2023 Sep; 133(18):. PubMed ID: 37498674
[TBL] [Abstract][Full Text] [Related]
29. Clonal Hematopoiesis and Cardiovascular Diseases: The Connection.
Mozzini C; Pagani M
Curr Probl Cardiol; 2022 Oct; 47(10):100962. PubMed ID: 34391764
[TBL] [Abstract][Full Text] [Related]
30. Clonal haematopoiesis of indeterminate potential: associations with heart failure incidence, clinical parameters and biomarkers.
Shi C; Aboumsallem JP; Suthahar N; de Graaf AO; Jansen JH; van Zeventer IA; Bracun V; de Wit S; Screever EM; van den Berg PF; Meijers WC; Gansevoort RT; Bakker SJL; van der Harst P; Silljé HHW; Huls G; de Boer RA
Eur J Heart Fail; 2023 Jan; 25(1):4-13. PubMed ID: 36221810
[TBL] [Abstract][Full Text] [Related]
31. [Clonal haematopoiesis is possibly a risk factor for cardiovascular disease].
Hansen PR
Ugeskr Laeger; 2020 Aug; 182(34):. PubMed ID: 32800058
[TBL] [Abstract][Full Text] [Related]
32. Clonal Hematopoiesis of Indeterminate Potential: Current Understanding and Future Directions.
Singh I; Singh A
Curr Oncol Rep; 2023 Jun; 25(6):539-547. PubMed ID: 36928826
[TBL] [Abstract][Full Text] [Related]
33. Clonal haematopoiesis: connecting ageing and inflammation in cardiovascular disease.
Jaiswal S; Libby P
Nat Rev Cardiol; 2020 Mar; 17(3):137-144. PubMed ID: 31406340
[TBL] [Abstract][Full Text] [Related]
34. Clonal hematopoiesis: Molecular and clinical implications.
Kusne Y; Xie Z; Patnaik MM
Leuk Res; 2022 Feb; 113():106787. PubMed ID: 35091334
[TBL] [Abstract][Full Text] [Related]
35. Clonal hematopoiesis and cardiovascular disease: deciphering interconnections.
Stein A; Metzeler K; Kubasch AS; Rommel KP; Desch S; Buettner P; Rosolowski M; Cross M; Platzbecker U; Thiele H
Basic Res Cardiol; 2022 Nov; 117(1):55. PubMed ID: 36355225
[TBL] [Abstract][Full Text] [Related]
36. Mendelian randomization supports bidirectional causality between telomere length and clonal hematopoiesis of indeterminate potential.
Nakao T; Bick AG; Taub MA; Zekavat SM; Uddin MM; Niroula A; Carty CL; Lane J; Honigberg MC; Weinstock JS; Pampana A; Gibson CJ; Griffin GK; Clarke SL; Bhattacharya R; Assimes TL; Emery LS; Stilp AM; Wong Q; Broome J; Laurie CA; Khan AT; Smith AV; Blackwell TW; Codd V; Nelson CP; Yoneda ZT; Peralta JM; Bowden DW; Irvin MR; Boorgula M; Zhao W; Yanek LR; Wiggins KL; Hixson JE; Gu CC; Peloso GM; Roden DM; Reupena MS; Hwu CM; DeMeo DL; North KE; Kelly S; Musani SK; Bis JC; Lloyd-Jones DM; Johnsen JM; Preuss M; Tracy RP; Peyser PA; Qiao D; Desai P; Curran JE; Freedman BI; Tiwari HK; Chavan S; Smith JA; Smith NL; Kelly TN; Hidalgo B; Cupples LA; Weeks DE; Hawley NL; Minster RL; ; Deka R; Naseri TT; de Las Fuentes L; Raffield LM; Morrison AC; Vries PS; Ballantyne CM; Kenny EE; Rich SS; Whitsel EA; Cho MH; Shoemaker MB; Pace BS; Blangero J; Palmer ND; Mitchell BD; Shuldiner AR; Barnes KC; Redline S; Kardia SLR; Abecasis GR; Becker LC; Heckbert SR; He J; Post W; Arnett DK; Vasan RS; Darbar D; Weiss ST; McGarvey ST; de Andrade M; Chen YI; Kaplan RC; Meyers DA; Custer BS; Correa A; Psaty BM; Fornage M; Manson JE; Boerwinkle E; Konkle BA; Loos RJF; Rotter JI; Silverman EK; Kooperberg C; Danesh J; Samani NJ; Jaiswal S; Libby P; Ellinor PT; Pankratz N; Ebert BL; Reiner AP; Mathias RA; Do R; ; Natarajan P
Sci Adv; 2022 Apr; 8(14):eabl6579. PubMed ID: 35385311
[TBL] [Abstract][Full Text] [Related]
37. Integrating clonal haematopoiesis into geriatric oncology: The ARCH between aging, cardiovascular disease and malignancy.
Neuendorff NR; Frenzel LP; Leuschner F; Fremd C
J Geriatr Oncol; 2021 Apr; 12(3):479-482. PubMed ID: 32978103
[No Abstract] [Full Text] [Related]
38. Clonal haematopoiesis is increased in early onset in systemic sclerosis.
Ricard L; Hirsch P; Largeaud L; Deswarte C; Jachiet V; Mohty M; Rivière S; Malard F; Tenon M; de Vassoigne F; Fain O; Gaugler B; Rossignol J; Delhommeau F; Mekinian A;
Rheumatology (Oxford); 2020 Nov; 59(11):3499-3504. PubMed ID: 32757002
[TBL] [Abstract][Full Text] [Related]
39. Somatic Mutations and Clonal Hematopoiesis as Drivers of Age-Related Cardiovascular Risk.
Haring B; Wissel S; Manson JE
Curr Cardiol Rep; 2022 Aug; 24(8):1049-1058. PubMed ID: 35657494
[TBL] [Abstract][Full Text] [Related]
40. Distinction of lymphoid and myeloid clonal hematopoiesis.
Niroula A; Sekar A; Murakami MA; Trinder M; Agrawal M; Wong WJ; Bick AG; Uddin MM; Gibson CJ; Griffin GK; Honigberg MC; Zekavat SM; Paruchuri K; Natarajan P; Ebert BL
Nat Med; 2021 Nov; 27(11):1921-1927. PubMed ID: 34663986
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
